Bridgewater Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.76M Buy
67,640
+2,450
+4% +$65.2K 0.1% 93
2025
Q4
$1.66M Sell
65,190
-1,005
-2% -$25.3K 0.11% 92
2025
Q3
$1.6M Buy
66,195
+1,442
+2% +$35.6K 0.11% 89
2025
Q2
$1.55M Sell
64,753
-840
-1% -$19.6K 0.12% 92
2025
Q1
$1.56M Sell
65,593
-306
-0.5% -$8.01K 0.14% 88
2024
Q4
$1.74M Sell
65,899
-2,777
-4% -$75.3K 0.18% 67
2024
Q3
$1.95M Sell
68,676
-76
-0.1% -$2.22K 0.2% 64
2024
Q2
$2.07M Buy
68,752
+4,779
+7% +$132K 0.26% 58
2024
Q1
$1.78M Sell
63,973
-4,864
-7% -$135K 0.27% 58
2023
Q4
$1.98M Buy
68,837
+180
+0.3% +$5.44K 0.3% 50
2023
Q3
$2.28M Sell
68,657
-316
-0.5% -$11.2K 0.37% 43
2023
Q2
$2.53M Sell
68,973
-84
-0.1% -$3.27K 0.51% 38
2023
Q1
$2.82M Sell
69,057
-117
-0.2% -$5.05K 0.61% 36
2022
Q4
$3.54M Sell
69,174
-8,718
-11% -$418K 0.86% 26
2022
Q3
$3.41M Buy
77,892
+10,574
+16% +$514K 0.94% 20
2022
Q2
$3.53M Buy
67,318
+200
+0.3% +$10.2K 0.73% 21
2022
Q1
$3.48M Buy
67,118
+164
+0.2% +$8.51K 0.84% 24
2021
Q4
$3.95M Buy
66,954
+256
+0.4% +$12.7K 0.87% 22
2021
Q3
$2.87M Buy
66,698
+6
+0% +$266 0.79% 29
2021
Q2
$2.61M Buy
66,692
+968
+1% +$37.6K 0.83% 28
2021
Q1
$2.61M Buy
+65,724
New +$2.33M 1.32% 15
2014
Q2
$906K Sell
32,170
-67,708
-68% -$1.93M 0.76% 41
2014
Q1
$3.04M Sell
99,878
-3,509
-3% -$105K 3.06% 6
2013
Q4
$3M Buy
+103,387
New +$3.01M 3.09% 6

Other funds holding PFE

Bridgewater Advisors's PFE Position: Q1 2026 in Review

Bridgewater Advisors increased its Pfizer (PFE) stake by 3.8% in Q1 2026, buying an estimated $65.2K and bringing the position to 67,640 shares worth $1.76M. The position accounts for 0.1% of the portfolio, ranked #93.

Bridgewater Advisors first reported a position in PFE in Q4 2013 and has held it in 24 quarters since. The position peaked at $3.95M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Bridgewater Advisors held 67,640 shares of Pfizer worth $1.76M as of Q1 2026.
  • Bridgewater Advisors bought 2,450 Pfizer shares in Q1 2026, an estimated $65.2K.
  • Pfizer made up 0.1% of Bridgewater Advisors's portfolio in Q1 2026, its #93 holding.
  • Bridgewater Advisors first reported a position in Pfizer in Q4 2013 and has held it in 24 quarters since.
  • Bridgewater Advisors's Pfizer position peaked at $3.95M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Bridgewater Advisors's 13F filing for Q1 2026, filed 14 May 2026.